Frequent allelic loss on chromosome 9 in hepatocellular carcinoma

International Journal of Cancer

Volumn 81, Issue 3, 1999, Pages 319-324

  Liew, Choong Tsek ^a   Li, Hiu Ming ^a   Lo, Kwok Wai ^a   Leow, Chon Kar ^a   Lau, Wan Yee ^a   Hin, Lin Yee ^a   Lim, Boon Kian ^a   Lai, Paul Bo San ^a   Chan, John Yeuk Hon ^a   Wang, Xiao Qiu ^a   Wu, Shan ^a   Lee, Joseph Chuen Kwun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; MICROSATELLITE DNA;

ADULT; ARTICLE; BASAL CELL NEVUS SYNDROME; CELL DIFFERENTIATION; CHROMOSOME 9; CLINICAL ARTICLE; FEMALE; GENE DELETION; GENETIC HETEROGENEITY; HEPATITIS B; HEPATITIS C; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0032936050     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990505)81:3<319::AID-IJC1>3.0.CO;2-K     Document Type: Article

References (18)

1. BIDEN, K., YOUNG, J., BUTTENSHAW, R., SEARLE, J., COOKSLEY, G., XU, D-B. and LEGETT, B., Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population. Hepatology, 25, 593-597 (1997).
2. BOIGE, V., LAURENT-PUIG, P., FOUCHET, P., FLÉJOU, J.F., MONGES, G., BEDOSSA, P., BIOULAC-SAGE, P., CAPRON, F., SCHMITZ, A., OLSCHWANG, S. and THOMAS, G., Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res., 57, 1986-1990 (1997).
3. CAIRNS, P. and 20 OTHERS, Frequency of homozygous deletion at p16/ CDKN2 in primary human tumors. Nature Genet., 11, 210-212 (1995).
4. CAIRNS, P., TORINO, K., EBY, Y. and SIDRANSKY, D., Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res., 54, 1422-1424 (1994).
5. COLEMAN, A., FOUNTAIN, J.W., NOBORI, T., OLOPADE, O.I., ROBERTSON, G., HOUSMAN, D.E. and LUGO, T.G., Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer and leukemia. Cancer Res., 54, 344-348 (1994).
6. FUJIMORI, M., TOKINO, T., HINO, O., KITAGAWA, T., IMAMURA, T., OKAMOTO, E., MITSUNOBU, M., ISHIKAWA, T., HARADA, H., YAGURA, M., MATSUBARA, K. and NAKAMURA, Y., Allelotype study of primary hepatocellular carcinoma, Cancer Res., 51, 89-93 (1991).
7. FUJIMOTO, Y., HAMPTON, L.L., WIRTH, P.J., WANG, N.J., XIE, J.P. and THORGEIRSSON, S.S., Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res., 54, 281-285 (1994).
8. HSU, H.C., PENG, S.Y., LAI, P.L., SHEU, J.C., CHEN, D.S., LIN, L.I., SLAGLE, B.L. and BUTEL, J.S., Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. Cancer, 73, 42-47 (1994).
9. KITA, R., NISHIDA, N., FUKUDA, Y., AZECHI, H., MATSUOKA, Y. KOMEDA, T., SANDO, T., NAKAO, K. and ISHIZAKI, K., Infrequent alterations of the p16 INK4A gene in liver cancer. Int. J. Cancer, 67, 176-180 (1996).
10. MERLO, A., GABRIELSON, E., ASKIN, F. and SIDRANSKY, D., Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res., 54, 640-642 (1994a).
11. MERLO, A., GABRIELSON, E., MABRY, M., VOLLMER, R., BAYLIN, S.B. and SIDRANSKY, D., Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p and 6q in primary human small cell lung cancer. Cancer Res., 54, 2322-2326 (1994b).
12. MUÑOZ, N. and BOSCH, X., Epidemiology of hepatocellular carcinoma In: K. Okuda, and K.G. Ishak (eds.), Neoplasm of the liver, p. 3, Springer, Tokyo (1987).
13. NAGAI, H., PINEAU, P., TIOLLAIS, P., BUENDIA, M.A. and DEJEAN, A., Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene, 14, 2927-2933 (1997).
14. SHANK, R.C., WOGAN, G.N., GIBSON, J.B. and NONDASUTA, A., Dietary aflatoxin and human liver cancer. II: Aflatoxin in market foods and foodstuffs of Thailand and Hong Kong. Food Cosmetics Toxicol., 10, 51-60 (1972).
15. SIMONEAU, A.R., SPRUCK III, C.H., GONZALEZ-ZULUETA, M., GONZALGO, M.L., CHAN, M.F., TSAI, Y.C., DEAN, M., STEVEN, K., HORN, T. and JONES, P.A., Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutation. Cancer Res., 56, 5039-5043 (1996).
16. STADLER, W.M., SHERMAN, J., BOHLANDER, S., ROULSTON, D., DREYLING, M., RUKSTALIS, D. and OLOPADE, O.I., Homozygous deletion within chromosome-1 bands 9p21-22 in bladder cancer. Cancer Res., 54, 2060-2063 (1994).
17. WIEST, J.S. and 12 OTHERS, Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative suppressor gene. Cancer Res., 57, 1-6 (1997).
18. YEH, S.H., CHEN, P.J., LAI, M.Y. and CHEN, D.S., Allelic loss on chromosome 4q and 16q in hepatocellular carcinoma: association with elevated alpha-feto protein production. Gastroenterology, 110, 184-192 (1996).